These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 4683426)

  • 1. The effects of dextrothyroxine on the kinetics of prothrombin activity: proposed mechanism of the potentiation of warfarin by D-thyroxine.
    Weintraub M; Breckenridge RT; Griner PF
    J Lab Clin Med; 1973 Feb; 81(2):273-9. PubMed ID: 4683426
    [No Abstract]   [Full Text] [Related]  

  • 2. Alterations in the effects of warfarin in dogs by halofenate: an influence upon the kinetics of prothrombin.
    Weintraub M; Griner PF
    Thromb Diath Haemorrh; 1975 Nov; 34(2):445-54. PubMed ID: 1198407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic and pharmacodynamic studies of acute interaction between warfarin enantiomers and chloramphenicol in rats.
    Yacobi A; Lai CM; Levy G
    J Pharmacol Exp Ther; 1984 Oct; 231(1):80-4. PubMed ID: 6491977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug interactions of amitriptyline and nortriptyline with warfarin in the rat.
    Loomis CW; Racz WJ
    Res Commun Chem Pathol Pharmacol; 1980 Oct; 30(1):41-58. PubMed ID: 7433768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies of the effects of heparin, Coumadin, and vitamin K on prothrombin metabolism and distribution in calves with the use of iodine-125-prothrombin. Characterization of the prothrombin system.
    Takeda Y
    J Lab Clin Med; 1970 Mar; 75(3):355-81. PubMed ID: 4984660
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of warfarin, phenylindanedione, tetrachloropyridinol, and chloro-vitamin K1 on prothrombin synthesis and vitamin K metabolism in normal and warfarin-resistant rats.
    Ren P; Laliberte RE; Bell RG
    Mol Pharmacol; 1974 May; 10(3):373-80. PubMed ID: 4851787
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacokinetic and pharmacodynamic studies of acute interaction between warfarin enantiomers and metronidazole in rats.
    Yacobi A; Lai CM; Levy G
    J Pharmacol Exp Ther; 1984 Oct; 231(1):72-9. PubMed ID: 6491976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sodium warfarin.
    O'Reilly RA
    Pharmacology; 1972; 8(1):181-90. PubMed ID: 4644647
    [No Abstract]   [Full Text] [Related]  

  • 9. Biosynthesis and clearance of prothrombin in warfarin-treated rats.
    Tollersrud OK; Kvalvaag AH; Helgeland L
    Biochim Biophys Acta; 1989 Jan; 1010(1):35-40. PubMed ID: 2909249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug interactions with warfarin.
    Hunninghake DB; Azarnoff DL
    Arch Intern Med; 1968 Apr; 121(4):349-52. PubMed ID: 5645709
    [No Abstract]   [Full Text] [Related]  

  • 11. Determination of the interaction of 3S-hydroxy-10,11-dihydroquinidine on the pharmacokinetics and pharmacodynamics of warfarin.
    Trenk D; Möhrke W; Warth L; Jähnchen E
    Arzneimittelforschung; 1993 Aug; 43(8):836-41. PubMed ID: 8216438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of warfarin on the intracellular processing of vitamin K-dependent proteins.
    Wu W; Bancroft JD; Suttie JW
    Thromb Haemost; 1996 Jul; 76(1):46-52. PubMed ID: 8819250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentiation of warfarin anticoagulation by topical testosterone ointment.
    Lorentz SM; Weibert RT
    Clin Pharm; 1985; 4(3):332-4. PubMed ID: 4006400
    [No Abstract]   [Full Text] [Related]  

  • 14. Relationship between international normalized ratio values, vitamin K-dependent clotting factor levels and in vivo prothrombin activation during the early and steady phases of oral anticoagulant treatment.
    D'Angelo A; Della Valle P; Crippa L; Fattorini A; Pattarini E; Viganò D'Angelo S
    Haematologica; 2002 Oct; 87(10):1074-80. PubMed ID: 12368163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose fluconazole therapy potentiates the hypoprothrombinemic response of warfarin sodium.
    Crussell-Porter LL; Rindone JP; Ford MA; Jaskar DW
    Arch Intern Med; 1993 Jan; 153(1):102-4. PubMed ID: 8422191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic formation of a prothrombin derivative.
    Ouyang C; Seegers WH; McCoy LE; Müller-Berghaus G
    Thromb Diath Haemorrh; 1971 Jun; 25(2):332-9. PubMed ID: 5568052
    [No Abstract]   [Full Text] [Related]  

  • 17. Phenylbutazone-warfarin interaction in the dog.
    Bachmann KA; Burkman AM
    J Pharm Pharmacol; 1975 Nov; 27(11):832-6. PubMed ID: 1491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Control of bleeding in splenectomized and coumadin treated animals: potentiation of ellagic acid effect with vitamin K.
    Agostino D; Cliffton EE
    Nagoya Med J; 1968 Apr; 14(1):65-73. PubMed ID: 5696331
    [No Abstract]   [Full Text] [Related]  

  • 19. [Rodenticidal activity of warfarin. 2. Kinetics].
    Niedner R; Kayser M; Meyer F
    Arzneimittelforschung; 1974 Jun; 24(6):522-4. PubMed ID: 4408102
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies of the epidemiology of anticoagulant-drug interactions.
    Kleinman PD; Griner PF
    Arch Intern Med; 1970 Sep; 126(3):522-3. PubMed ID: 5450943
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.